[1] |
XIAO LL, WU XX, CHEN JJ, et al. Progress in hepatitis B virus-related acute-on-chronic liver failure treatment in China: A large, multicenter, retrospective cohort study using a propensity score matching analysis[J]. Hepatobiliary Pancreat Dis Int, 2021, 20(6): 535-541. DOI: 10.1016/j.hbpd.2021.05.010.
|
[2] |
LIU M, ZHANG XQ, MAO Q. Features of acute-on-chronic pre-liver failure and establishment of a predictive model for risk of acute-on-chronic liver failure[J]. J Clin Hepatol, 2012, 28(10): 732-734. https://www.cnki.com.cn/Article/CJFDTOTAL-LCGD201210005.htm
刘明, 张绪清, 毛青. 慢加急性肝衰竭前期的概念及预警模型[J]. 临床肝胆病杂志, 2012, 28(10): 732-734. https://www.cnki.com.cn/Article/CJFDTOTAL-LCGD201210005.htm
|
[3] |
TAN NH, CHEN B, PENG J, et al. Treg/Th17 cell balance in patients with hepatitis B virus-related acute-on-chronic liver failure at different disease stages[J]. Biomed Res Int, 2021, 2021: 9140602. DOI: 10.1155/2021/9140602.
|
[4] |
ZENG Y, LI Y, XU Z, et al. Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure[J]. J Med Virol, 2019, 91(8): 1510-1518. DOI: 10.1002/jmv.25466.
|
[5] |
WEISS E, de la GRANGE P, DEFAYE M, et al. Characterization of blood immune cells in patients with decompensated cirrhosis including ACLF[J]. Front Immunol, 2020, 11: 619039. DOI: 10.3389/fimmu.2020.619039.
|
[6] |
Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
|
[7] |
Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B: a 2015 update[J]. J Clin Hepatol, 2015, 31(12): 1941-1960. DOI: 10.3969/j.issn.1001-5256.2015.12.002.
中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015年更新版)[J]. 临床肝胆病杂志, 2015, 31(12): 1941-1960. DOI: 10.3969/j.issn.1001-5256.2015.12.002.
|
[8] |
TRIANTAFYLLOU E, WOOLLARD KJ, MCPHAIL M, et al. The role of monocytes and macrophages in acute and acute-on-chronic liver failure[J]. Front Immunol, 2018, 9: 2948. DOI: 10.3389/fimmu.2018.02948.
|
[9] |
ZENG YF, XU Z, LU LR, et al. The possible role and clinical implication of myeloid-derived suppressor cells in the peripheral blood of patients with hepatitis B virus-related acute-on- chronic liver failure[J]. Chin J Infect Dis, 2016, 34(4): 215-222. DOI: 10.3760/cma.j.issn.1000-6680.2016.04.003.
曾映夫, 许镇, 陆丽蓉, 等. 髓源性抑制细胞在乙型肝炎病毒相关慢加急性(亚急性)肝衰竭患者外周血中的作用及临床意义[J]. 中华传染病杂志, 2016, 34(4): 215-222. DOI: 10.3760/cma.j.issn.1000-6680.2016.04.003.
|
[10] |
CHIU DK, XU IM, LAI RK, et al. Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26[J]. Hepatology, 2016, 64(3): 797-813. DOI: 10.1002/hep.28655.
|
[11] |
REN JP, WANG L, ZHAO J, et al. Decline of miR-124 in myeloid cells promotes regulatory T-cell development in hepatitis C virus infection[J]. Immunology, 2017, 150(2): 213-220. DOI: 10.1111/imm.12680.
|
[12] |
HAIST M, STEGE H, GRABBE S, et al. The functional crosstalk between myeloid-derived suppressor cells and regulatory T cells within the immunosuppressive tumor microenvironment[J]. Cancers (Basel), 2021, 13(2): 210. DOI: 10.3390/cancers13020210.
|
[13] |
BAO J, CUI D, WANG X, et al. Decreased frequencies of Th17 and Tc17 cells in patients infected with avian influenza A (H7N9) virus[J]. J Immunol Res, 2019, 2019: 1418251. DOI: 10.1155/2019/1418251.
|
[14] |
LVCKEL C, PICARD F, HUBER M. Tc17 biology and function: Novel concepts[J]. Eur J Immunol, 2020, 50(9): 1257-1267. DOI: 10.1002/eji.202048627.
|
[15] |
ZHANG JP, YAN J, XU J, et al. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients[J]. J Hepatol, 2009, 50(5): 980-989. DOI: 10.1016/j.jhep.2008.12.033.
|
[16] |
LIANG XS, LI CZ, ZHOU Y, et al. Changes in circulating Foxp3(+) regulatory T cells and interleukin-17-producing T helper cells during HBV-related acute-on-chronic liver failure[J]. World J Gastroenterol, 2014, 20(26): 8558-8571. DOI: 10.3748/wjg.v20.i26.8558.
|
[17] |
ZHANG GL, XU SC, ZHANG T, et al. Effects of Tc17 cells on disease severity and HBV-DNA elimination in patients with HBV related acute-on-chronic liver failure[J]. J Sun Yat-sen Univ(Med Sci), 2019, 40(5): 739-746. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2019.0103.
张耿林, 徐士丞, 张婷, 等. Tc17细胞对乙肝相关慢加急性肝衰竭病情进展及乙肝病毒清除的影响[J]. 中山大学学报(医学科学版), 2019, 40(5): 739-746. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2019.0103.
|
[18] |
ZHANG GL, ZHANG T, ZHAO QY, et al. Increased IL-17-producing CD8+ T cell frequency predicts short-term mortality in patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Ther Clin Risk Manag, 2018, 14: 2127-2136. DOI: 10.2147/TCRM.S184809.
|